novustherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Eledon Pharmaceuticals: Developing precision therapeutics that target the CD40 Ligand |
| Description | Developing next generation anti-CD40 Ligand (CD40L) pathway Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 3.33.152.147 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
novustherapeutics.com Valuation
|
US$733,920
Last updated: 2023-05-12 23:28:35
novustherapeutics.com has Semrush global rank of 14,421,612. novustherapeutics.com has an estimated worth of US$ 733,920, based on its estimated Ads revenue. novustherapeutics.com receives approximately 84,684 unique visitors each day. Its web server is located in United States, with IP address 3.33.152.147. According to SiteAdvisor, novustherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$733,920 |
| Daily Ads Revenue | US$678 |
| Monthly Ads Revenue | US$20,324 |
| Yearly Ads Revenue | US$243,888 |
| Daily Unique Visitors | 5,646 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| novustherapeutics.com. | A | 599 | IP: 3.33.152.147 |
| novustherapeutics.com. | A | 599 | IP: 15.197.142.173 |
| novustherapeutics.com. | NS | 3600 | NS Record: ns39.domaincontrol.com. |
| novustherapeutics.com. | NS | 3600 | NS Record: ns40.domaincontrol.com. |
| novustherapeutics.com. | MX | 3600 | MX Record: 10 novustherapeutics-com.mail.protection.outlook.com. |
| novustherapeutics.com. | TXT | 3600 | TXT Record: ZOOM_verify_aFXxFKf3SNW872LbjvsklA |
| novustherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com include:mail.zendesk.com -all |
| novustherapeutics.com. | TXT | 3600 | TXT Record: MS=ms37587938 |
HtmlToTextCheckTime:2023-05-12 23:28:35
| --> info@eledon.com +1 949.238.8090 Search for: Home About Us Company Overview Leadership Team Board of Directors Governance R&D R&D Overview CD40L Pathway Pipeline Tegoprubart Phase 1 KLH Challenge Investors News Events Presentations Stock Information SEC Filings Investor FAQs Join the Team Contact Us Developing precision therapies that target the CD40 Ligand pathway for use in organ and cellular transplantation, and for the treatment of autoimmune and neurodegenerative diseases Developing precision therapies that target the CD40 Ligand pathway for use in organ and cellular transplantation, and for the treatment of autoimmune and neurodegenerative diseases Developing precision therapies that target the CD40 Ligand pathway for use in organ and cellular transplantation, and for the treatment of autoimmune and neurodegenerative diseases Developing precision therapies that target the CD40 Ligand pathway for use in organ and cellular transplantation, and for the treatment of autoimmune |
HTTP Headers
HTTP/1.1 405 Not Allowed Server: awselb/2.0 Date: Mon, 20 Dec 2021 05:57:21 GMT Content-Length: 0 Connection: keep-alive WAFRule: HTTPMethodNOTAllowed |
novustherapeutics.com Whois Information
Domain Name: NOVUSTHERAPEUTICS.COM Registry Domain ID: 2097545101_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-01-04T23:05:13Z Creation Date: 2017-02-13T22:14:42Z Registry Expiry Date: 2022-02-13T22:14:42Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS39.DOMAINCONTROL.COM Name Server: NS40.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-23T07:47:52Z <<< |